Progesterone isused to help prevent changes in the uterus (womb) in women who are taking conjugated estrogens after menopause. It is also used to properly regulate the menstrual cycle and treat unusual stopping of menstrual periods (amenorrhea) in women who are still menstruating.
This report contains market size and forecasts of Progesterone Drugs in global, including the following market information:
- Global Progesterone Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
- Global Progesterone Drugs Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Progesterone Drugs companies in 2022 (%)
The global Progesterone Drugs market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Capsules Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Progesterone Drugs include Merck, Pfizer, BionPharma, Teva Pharmaceutical Industries, Aquatic Remedies, Sofgen Pharmaceuticals, Virtus Pharmaceuticals, Intas Pharmaceuticals and Zhejiang Xianju Pharmaceutical, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Progesterone Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Progesterone Drugs Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Progesterone Drugs Market Segment Percentages, by Type, 2022 (%)
Global Progesterone Drugs Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Progesterone Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospital
- Clinic
- Pharmacy
- Other
Global Progesterone Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Progesterone Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Progesterone Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Progesterone Drugs revenues share in global market, 2022 (%)
- Key companies Progesterone Drugs sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Progesterone Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck
- Pfizer
- BionPharma
- Teva Pharmaceutical Industries
- Aquatic Remedies
- Sofgen Pharmaceuticals
- Virtus Pharmaceuticals
- Intas Pharmaceuticals
- Zhejiang Xianju Pharmaceutical
- Hubei Dongxin Pharmaceutical
- Zhejiang Medicine
- Zhejiang Aisheng Pharmaceutical
- Beijing Winsunny Pharmaceutical
